NMDAEpsilon4 Polyclonal Antibody

N-methyl-D-aspartate (NMDA) receptors are a class of ionotropic glutamate receptors. NMDA channel has been shown to be involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. NMDA receptor channels are heteromers composed of the key receptor subunit NMDAR1 (GRIN1) and 1 or more of the 4 NMDAR2 subunits: nMDAR2A (GRIN2A), NMDAR2B (GRIN2B), NMDAR2C (GRIN2C), and NMDAR2D (GRIN2D).

The NMDAEpsilon4 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of NMDAEpsilon4 protein expression. This antibody is produced using advanced techniques and rigorous quality control measures to ensure optimal performance and reliability.

The NMDAEpsilon4 Polyclonal Antibody exhibits exceptional affinity and selectivity towards the NMDAEpsilon4 protein, making it an ideal choice for various applications, including western blotting, immunohistochemistry, and immunofluorescence. Its high sensitivity allows for the detection of even low levels of NMDAEpsilon4 protein, enabling accurate quantification and analysis.

This antibody is manufactured using state-of-the-art technology and undergoes stringent purification processes to ensure high purity and minimal background noise. Its polyclonal nature enhances its ability to recognize multiple epitopes on the target protein, further enhancing its specificity and sensitivity.

The NMDAEpsilon4 Polyclonal Antibody is supplied in a convenient and ready-to-use format, allowing for easy integration into laboratory workflows. Its long shelf life and stability ensure consistent and reliable results over an extended period.

In summary, the NMDAEpsilon4 Polyclonal Antibody is a superior tool for the detection and analysis of NMDAEpsilon4 protein expression. Its exceptional specificity, sensitivity, and reliability make it an invaluable asset for researchers and scientists in various fields, including neuroscience, molecular biology, and drug discovery.